Praxis Medical Insights

Est. 2024 • Clinical Guidelines Distilled

Made possible by volunteer editors from the University of Calgary & University of Alberta

Last Updated: 12/3/2025

MRI Brain Imaging Guidelines

Initial Imaging Approach

  • The American College of Radiology recommends MRI brain without contrast as the initial study for new-onset seizures, as noncontrast imaging adequately identifies structural lesions and defines the epileptogenic zone 1
  • For altered mental status or delirium, CT head without contrast is the first-line test in acute settings, while MRI brain without contrast is appropriate as a second-line test when CT is unrevealing and occult pathology is suspected 2, 3
  • The American College of Radiology suggests MRI brain without and with contrast for comprehensive posterior fossa evaluation in cases of ataxia, as contrast is particularly important for detecting masses, inflammatory processes, or vascular lesions 4

Contrast-Enhanced Imaging

  • The American College of Radiology recommends MRI brain with and without contrast for suspected brain tumors, as contrast enhancement is crucial for demonstrating leaky vasculature and characterizing tumor extent 5
  • For brain metastases screening, MRI brain with and without contrast is recommended, as contrast is essential for detecting small metastatic lesions 5, 6
  • The American College of Radiology suggests MRI brain with and without contrast for posttreatment tumor surveillance, as noncontrast MRI alone cannot distinguish residual/recurrent enhancing tumor from treatment effects 5, 6

Clinical Decision Algorithm

  • The American College of Radiology recommends determining the clinical indication, assessing urgency and available resources, deciding on contrast based on suspected pathology, and considering patient-specific factors, such as renal function and history of malignancy, when deciding on MRI brain imaging 1, 2, 3, 7, 5, 8

Interpretation Challenges

  • The American College of Radiology notes that pseudoprogression can mimic tumor progression on conventional MRI, typically occurring 3-6 months post-radiotherapy, and that enhancement is not reliable in patients receiving bevacizumab therapy 5, 6
  • Conventional MRI has modest sensitivity and specificity for differentiating progressive disease from treatment effects, highlighting the need for careful interpretation and consideration of clinical context 5, 6

MRI Brain for Re-evaluation of Abnormal Gray Matter

Rationale for Noncontrast MRI

  • MRI brain without IV contrast is the optimal imaging modality for gray matter evaluation because of its superior soft-tissue characterization and sensitivity to gray matter abnormalities, as recommended by the American College of Radiology 9

Technical Considerations

  • The American College of Radiology suggests including susceptibility-weighted sequences (T2* or SWI) to detect iron deposition in deep gray matter structures like the basal ganglia and thalamus, which appears as T2-hypointensity and may indicate neurodegenerative processes 9

Clinical Context Matters

  • For suspected tumor recurrence or new mass, MRI with and without contrast becomes necessary to distinguish residual/recurrent enhancing lesions from treatment effects, as suggested by the American College of Radiology 10
  • In cases where inflammatory or infectious processes are in the differential diagnosis, the American College of Radiology recommends considering MRI brain WITH and WITHOUT contrast 11

REFERENCES

1

acr appropriateness criteria® seizures and epilepsy. [LINK]

Journal of the American College of Radiology, 2020

4

acr appropriateness criteria<sup>®</sup> ataxia. [LINK]

Journal of the American College of Radiology, 2019

5

acr appropriateness criteria® brain tumors. [LINK]

Journal of the American College of Radiology, 2025

6

Management Approach for Brain Lesions Identified on MRI [LINK]

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

8

MRI with Contrast: Indications and Guidelines [LINK]

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

10

acr appropriateness criteria® brain tumors. [LINK]

Journal of the American College of Radiology, 2025

11

acr appropriateness criteria<sup>®</sup> sinonasal disease. [LINK]

Journal of the American College of Radiology, 2017